AIM ImmunoTech (AIM) News Today $0.21 -0.01 (-4.54%) (As of 12/11/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period AIM’s Clinical Strategy Under Incumbent Board Has Totally FailedDecember 11 at 3:03 PM | markets.businessinsider.comAIM's Clinical Strategy Under Incumbent Board Has Totally FailedDecember 11 at 7:30 AM | globenewswire.comGlass Lewis Recommends AIM ImmunoTech Shareholders Vote "FOR" Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. MitchellDecember 10 at 11:37 AM | uk.finance.yahoo.comGlass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K.December 10 at 10:20 AM | businesswire.comAmpligen Co-Inventor and Former CEO Agrees to Join AIM Scientific Advisory Board if Kellner Group Nominees Are ElectedDecember 10 at 7:30 AM | globenewswire.comAIM ImmunoTech Participates in Virtual Investor KOL Connect SegmentDecember 6, 2024 | globenewswire.comKellner Group Urges Stockholders of AIM Immunotech to Vote the Gold CardDecember 6, 2024 | globenewswire.comISS Recommends AIM ImmunoTech Shareholders Vote "FOR" Company Nominees Nancy K. Bryan and Dr. William M. MitchellDecember 5, 2024 | finance.yahoo.comAIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the BoardDecember 3, 2024 | finance.yahoo.comKellner Group urges AIM ImmunoTech stockholders to vote for its nomineesDecember 3, 2024 | markets.businessinsider.comKellner Group Urges Stockholders of AIM Immunotech to Vote the Gold CardDecember 2, 2024 | globenewswire.comAIM ImmunoTech announces cash conservation plan, committment to AmpligenNovember 28, 2024 | markets.businessinsider.comAIM ImmunoTech Refutes Activist Group’s False and Misleading ClaimsNovember 28, 2024 | finance.yahoo.comAIM ImmunoTech Aligns Compensation with Shareholder StrategyNovember 27, 2024 | tipranks.comAIM ImmunoTech Refutes Activist Group's False and Misleading ClaimsNovember 27, 2024 | businesswire.comKellner Group isses letter to stockholders of AIM ImmunoTechNovember 26, 2024 | markets.businessinsider.comKellner Group Urges Stockholders of AIM Immunotech to Vote Enclosed Gold CardNovember 26, 2024 | markets.businessinsider.comAIM ImmunoTech Inc. (NYSE:AIM) Director Buys $15,571.07 in StockNovember 22, 2024 | insidertrades.comThomas K. Equels Acquires 60,110 Shares of AIM ImmunoTech Inc. (NYSE:AIM) StockNovember 21, 2024 | insidertrades.comAIM ImmunoTech announces data pubished on Part 1 study on AmpligenNovember 19, 2024 | markets.businessinsider.comKellner Group urgers stockholders of AIM Immunotech to vote for nomineesNovember 19, 2024 | markets.businessinsider.comAIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of CancerNovember 19, 2024 | globenewswire.comAIM ImmunoTech Inc. (AMEX:AIM) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comAIM Down on Q3 ResultsNovember 16, 2024 | baystreet.caAIM ImmunoTech files to sell 9.31M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.comAIM ImmunoTech Inc (AIM) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...November 16, 2024 | finance.yahoo.comAIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comAIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 15, 2024 | globenewswire.comKellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card Now for Desperately Needed Change to the AIM BoardNovember 14, 2024 | finance.yahoo.comInsights into AIM ImmunoTech's Upcoming EarningsNovember 14, 2024 | benzinga.comExploring AIM ImmunoTech's Earnings ExpectationsNovember 7, 2024 | benzinga.comAIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and WebcastNovember 6, 2024 | globenewswire.comAIM ImmunoTech price target lowered to $1 from $2 at MaximOctober 23, 2024 | markets.businessinsider.comAIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLCOctober 9, 2024 | markets.businessinsider.comAIM ImmunoTech (AMEX:AIM) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comAIM ImmunoTech (AMEX:AIM) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comAIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of EndometriosisOctober 3, 2024 | globenewswire.comAIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct OfferingSeptember 30, 2024 | finance.yahoo.comAIM ImmunoTech to Participate in Virtual Investor CEO Connect SegmentSeptember 27, 2024 | globenewswire.comAIM Reports Positive Preliminary Data From Phase 1b/2 Study Of Ampligen, Imfinzi As CombinationSeptember 19, 2024 | markets.businessinsider.comAIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer ResearchAugust 20, 2024 | globenewswire.comAIM ImmunoTech Inc. (AMEX:AIM) Q2 2024 Earnings Call TranscriptAugust 17, 2024 | msn.comAIM ImmunoTech Inc.: AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 16, 2024 | finanznachrichten.deAIM ImmunoTech Inc. (AIM) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | seekingalpha.comAIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 16, 2024 | globenewswire.comSamson Rock Capital LLP - Form 8.3 - Trident Royalties PlcAugust 13, 2024 | uk.finance.yahoo.comJim Click's 2006 Ford Mustang FR500C Race Car Hits Bring a Trailer AuctionAugust 13, 2024 | msn.com535p?! This broker just hiked the forecast for the Rolls-Royce share priceAugust 13, 2024 | msn.comAIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Conference Call and WebcastAugust 13, 2024 | globenewswire.comAIM ImmunoTech Announces Release of the Next CEO Corner SegmentJuly 29, 2024 | globenewswire.com Get AIM ImmunoTech News Delivered to You Automatically Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol AIM Media Mentions By Week AIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AIM News Sentiment▼0.320.95▲Average Medical News Sentiment AIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AIM Articles This Week▼92▲AIM Articles Average Week Get AIM ImmunoTech News Delivered to You Automatically Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VNRX News ESLA News BIVI News KZR News CELU News PASG News GANX News DYAI News ACAB News RLYB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AIM) was last updated on 12/11/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
